Recently, GeneQuantum Healthcare, a global innovative biological company dedicated to the development of breakthrough innovative biological conjugates, was awarded the honorary titles of "Unicorn-to-be " in Jiangsu Province and "Enterprise Technology Center" in Suzhou City.

On November 25, 2021, the "Notice on the Release of the Evaluation Results of Unicorn Enterprises and Gazelle Enterprises in Jiangsu High-tech Industrial Development Zone in 2021" (Su Shengli [2021] No. 110) announced the list of selected enterprises in the long-awaited, committed to GeneQuantum Healthcare (Suzhou) Co., Ltd., a global innovative biological company engaged in the development of breakthrough innovative biological conjugated drugs, was honorably selected as a "Unicorn-to-be" in Jiangsu Province.

"Unicorn-to-be" is a term in the investment world, which means that it has good potential in terms of team, industry direction, technological innovation ability and development trend, and has unique core technology or disruptive business model. The market valuation is relatively high and the growth rate is relatively high. Fast business. Potential unicorn companies in Jiangsu Province are required to have received investment and have not yet been listed.

On November 13, 2021, according to the "Trial Measures for the Management of the Identification and Management of Suzhou Municipal Technology Centers" (Su Fu [1997] No. 115), the company will apply for it, and it will be recommended by local governments and reviewed by the Municipal Bureau of Industry and Information Technology, the Municipal Development and Reform Commission, and the Municipal Science and Technology Bureau. , approved by the municipal government, and GeneQuantum Healthcare (Suzhou) Co., Ltd. has been recognized by the twenty-fifth batch of municipal enterprise technology centers in Suzhou.

Enterprise technology center refers to the technology research and development and innovation institution established by the enterprise according to the needs of market competition and development strategy planning. By encouraging and supporting enterprises to establish technology centers, giving full play to the main role of enterprises in technological innovation, establishing and improving systems and mechanisms for technological R&D and innovation in enterprises' leading industries, and promoting enterprises to become the main body of R&D investment, technological innovation activities and application of innovative results, and continuously improve Enterprise independent innovation ability, resource integration ability and market competitiveness.

The recognized enterprises will take this opportunity to further improve the organizational structure and operation mechanism, increase investment in research and development, and continuously enhance the innovation ability of enterprise technology centers. At the same time, the government will strengthen the guidance and services for the construction of enterprise technology centers. Plans, tax incentives and other aspects to further increase support.

About GeneQuantum Healthcare

GeneQuantum Healthcare (Suzhou) Co., Ltd. is a high-tech biopharmaceutical company dedicated to the development of innovative biotherapeutics. The company is focused on the development of a new generation of bioconjugate therapeutics to meet the unmet medical needs of cancer patients globally. For more information, visit www.genequantum.com.